Pantoprazole Sodium
Pantoprazole Sodium is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Pantoprazole Sodium; Generic name: PANTOPRAZOLE SODIUM; Manufacturer: QPharma Inc.
| Brand name | Pantoprazole Sodium |
|---|---|
| Generic name | PANTOPRAZOLE SODIUM |
| Manufacturer | QPharma Inc |
| Used for | 1 INDICATIONS AND USAGE Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) (1.1) Maintenance of Healing of Erosive Esophagitis (1.2) Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome (1.3) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of eros |
| Dosage | 2 DOSAGE AND ADMINISTRATION * Controlled studies did not extend beyond 12 months See full prescribing information for administration instructions Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD ( 2.1 ) Adults 40 mg Once Daily for up to 8 wks Children (5 years and older) ≥ 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks ≥ 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis ( 2.1 ) Adults 40 mg Once Daily* Pathological Hypersecretory Conditions In |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e200326-8885-18d0-e063-6294a90aad2f |